Ropes & Gray advised Pfizer on the deal. Pfizer announced a strategic collaboration with Flagship Pioneering to create a new pipeline of innovative medicines. The collaboration...
Pfizer’s Strategic Collaboration with Flagship Pioneering
Pfizer’s $25 Million Strategic Investment in CellCentric
Ropes & Gray advised Pfizer on the deal. Pfizer announced its strategic investment in and collaboration with CellCentric, which includes $25 million to help finance further development...
Ovid Therapeutics’ Collaboration with Graviton Bioscience
Ropes & Gray advised Ovid Therapeutics on the deal. Ovid Therapeutics announced a collaboration with Graviton Bioscience Corporation under which Ovid obtained exclusive rights to develop...
National Resilience’s $110 Million Alliance with Bluebird Bio to Develop Cell Therapies
Ropes & Gray advised National Resilience on the deal. National Resilience, Inc., a biopharmaceutical manufacturing specialist, closed a strategic alliance with bluebird bio, Inc., to accelerate...
SmartLabs’ $250 Million Series B Financing
Ropes & Gray represented SmartLabs in the transaction. SmartLabs, a Boston-based Laboratory-as-a-Service leader, raised $250 million in a Series B financing that will be used to help...
Blackstone Life Sciences’ $250 Million Investment in Cellex Group
Noerr and Morgan, Lewis & Bockius advised Cellex Cell Professionals GmbH on the deal. Ropes & Gray advised Blackstone Life Sciences. The Dresden-based Cellex Group announced...